TERM ID="NYU_TERM_1" STRING="BENCHMRK studies" FREQUENCY=1 START=999 END=1015 LEMMA="BENCHMRK STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="H/R" FREQUENCY=1 START=1262 END=1265 LEMMA="H/R" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="HIV" FREQUENCY=1 START=174 END=177 LEMMA="HIV" LEMMA_FREQUENCY=1 HEAD_TERM="HIV" HEAD_LEMMA="HIV" TERM_PATTERN_TYPE="chemical"
TERM ID="NYU_TERM_4" STRING="K/R" FREQUENCY=1 START=1273 END=1276 LEMMA="K/R" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="Lopinavir/r" FREQUENCY=1 START=1369 END=1380 LEMMA="LOPINAVIR/R" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="Raltegravir" FREQUENCY=3 START=66 END=77 LEMMA="RALTEGRAVIR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_7" STRING="Raltegravir" FREQUENCY=3 START=394 END=405 LEMMA="RALTEGRAVIR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_8" STRING="Raltegravir" FREQUENCY=3 START=820 END=831 LEMMA="RALTEGRAVIR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_9" STRING="SWITCHMRK studies" FREQUENCY=1 START=1332 END=1349 LEMMA="SWITCHMRK STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="SWITCHMRK studies non-inferiority" FREQUENCY=1 START=1332 END=1365 LEMMA="NON-INFERIORITY SWITCHMRK STUDY" LEMMA_FREQUENCY=1 HEAD_TERM="non-inferiority" HEAD_LEMMA="NON-INFERIORITY"
TERM ID="NYU_TERM_11" STRING="approved HIV-1 integrase inhibitor" FREQUENCY=1 START=89 END=123 LEMMA="APPROVED HIV-1 INTEGRASE INHIBITOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="archived resistance mutationts" FREQUENCY=1 START=1530 END=1560 LEMMA="ARCHIVED RESISTANCE MUTATIONT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="background therapy" FREQUENCY=1 START=1564 END=1582 LEMMA="BACKGROUND THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="cellular host DNA" FREQUENCY=1 START=220 END=237 LEMMA="CELLULAR HOST DNA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="containing Lopinavir/r" FREQUENCY=1 START=1462 END=1484 LEMMA="CONTAINING LOPINAVIR/R" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="emerging paradigm" FREQUENCY=1 START=606 END=623 LEMMA="EMERGING PARADIGM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="functional monotherapy" FREQUENCY=1 START=1596 END=1618 LEMMA="FUNCTIONAL MONOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="hepatic cytochrone P450 activity" FREQUENCY=1 START=464 END=496 LEMMA="HEPATIC CYTOCHRONE P450 ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="hepatic impairment" FREQUENCY=1 START=582 END=600 LEMMA="HEPATIC IMPAIRMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="induction" FREQUENCY=1 START=446 END=455 LEMMA="INDUCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="integrase gene resistance mutations" FREQUENCY=1 START=1206 END=1241 LEMMA="INTEGRASE GENE RESISTANCE MUTATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="integrase inhibitors" FREQUENCY=1 START=11 END=31 LEMMA="INTEGRASE INHIBITOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="mild-to-moderate" FREQUENCY=1 START=565 END=581 LEMMA="MILD-TO-MODERATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="mild-to-moderate hepatic impairment" FREQUENCY=1 START=565 END=600 LEMMA="HEPATIC IMPAIRMENT MILD-TO-MODERATE" LEMMA_FREQUENCY=1 HEAD_TERM="hepatic impairment" HEAD_LEMMA="HEPATIC IMPAIRMENT"
TERM ID="NYU_TERM_25" STRING="non-inferiority" FREQUENCY=1 START=1350 END=1365 LEMMA="NON-INFERIORITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="optimized background therapy" FREQUENCY=1 START=912 END=940 LEMMA="OPTIMIZED BACKGROUND THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="oral route" FREQUENCY=1 START=361 END=371 LEMMA="ORAL ROUTE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="pivotal phase III" FREQUENCY=1 START=267 END=284 LEMMA="PIVOTAL PHASE III" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="raltegravir" FREQUENCY=1 START=1624 END=1635 LEMMA="RALTEGRAVIR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_30" STRING="regulatory agencies" FREQUENCY=1 START=323 END=342 LEMMA="REGULATORY AGENCY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="renal insufficiency" FREQUENCY=1 START=539 END=558 LEMMA="RENAL INSUFFICIENCY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="salvage therapy" FREQUENCY=2 START=640 END=655 LEMMA="SALVAGE THERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_33" STRING="salvage therapy" FREQUENCY=2 START=961 END=976 LEMMA="SALVAGE THERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_34" STRING="strand transfer step" FREQUENCY=1 START=146 END=166 LEMMA="STRAND TRANSFER STEP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="treatment-experienced patients" FREQUENCY=1 START=35 END=65 LEMMA="TREATMENT-EXPERIENCED PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="treatment-experienced patients Raltegravir" FREQUENCY=1 START=35 END=77 LEMMA="RALTEGRAVIR TREATMENT-EXPERIENCED PATIENT" LEMMA_FREQUENCY=1 HEAD_TERM="Raltegravir" HEAD_LEMMA="RALTEGRAVIR"
TERM ID="NYU_TERM_37" STRING="viral load" FREQUENCY=1 START=673 END=683 LEMMA="VIRAL LOAD" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_38" STRING="virogically suppressed patients" FREQUENCY=1 START=1410 END=1441 LEMMA="VIROGICALLY SUPPRESSED PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="virological failure" FREQUENCY=1 START=1147 END=1166 LEMMA="VIROLOGICAL FAILURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="week effect" FREQUENCY=1 START=412 END=423 LEMMA="WEEK EFFECT" LEMMA_FREQUENCY=1
